Insider filing · AGIO
Rahul D. Ballal
Director
profile →
Agios Pharmaceuticals, Inc.
AGIO · Healthcare · 29 filings in 24 months
ticker →
Rahul D. Ballal sold $1.0M of Agios Pharmaceuticals (AGIO)
Executed Nov 7 2024, disclosed Nov 12 2024, 5 days later.
Value, as filed
$1.0M
18,500 sh across 4 lots
Executed
Nov 7 2024
the trade date, as filed
Disclosed
Nov 12 2024
5 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RBRahul D. Ballal (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Agios Pharmaceuticals, Inc. (AGIO).
The name
AGIOHealthcare · Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the Unite…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→